The Board of Directors considered and approved audited standalone & consolidated financial results for the quarter and year ended March 31, 2026 and took on record audit report on these ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The board approved audited standalone and consolidated financial results for FY2025-26. Standalone revenue grew 6.4% to Rs 6,896.84 lakhs with PAT up 20.1% to Rs 1,942.68 lakhs. However, consolidated PAT declined sharply to Rs 5,190.05 lakhs from Rs 8,828.77 lakhs previously, mainly due to lower share in associate profit (Rs 4,901.61 lakhs vs Rs 8,534.81 lakhs). The auditors issued unmodified opinions on standalone results. On consolidated basis, the auditors noted going concern issues at two subsidiaries: ISGEC Investment PTE LTD reported a loss of S$3.5 million with liabilities exceeding assets, and Bioeq Energy Holdings Corp has capital deficiency of P2.84 billion. The board recommended a dividend of Rs 500 per share (500% of face value).
Standalone operations showed healthy growth, but consolidated results reflect a significant profit decline due to lower associate earnings. The going concern warnings on foreign subsidiaries warrant monitoring. The strong dividend payout signals confidence in standalone profitability.